Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1987)	10/18/2007 10:11:59 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

ASPV opened with an UG today after it announced that it had agreed to be munched by Galnica at $26 <g> bigcharts.marketwatch.com Aspreva to be Acquired by Galenica For US$915 Million Thursday October 18, 9:00 am ET - All-Cash Transaction Valued at US$26.00 Per Share - VICTORIA, Oct. 17 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV - News; TSX: ASV - News) today announced that it has entered into a combination agreement with Galenica Group (SWX: GALN - News) under which Galenica, through a wholly-owned Canadian subsidiary, will acquire all of Aspreva's outstanding shares at a price of US$26.00 per share in cash. The total value of the transaction is approximately US$915 million. Snip A C.C. has been scheduled for 1:00PM Bernard